Press releases
- Press releases
- Browse
Press releases
Bridgehead International provides Experts' Report for listing of AGI Therapeutics plc on AIM and IEX
AGI Therapeutics plc, announced its admission to trading on AIM and IEX in a €42.5 Million (£29.2 million) Placing on 27 February 2006, which was arranged by Davy. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Sep 2010 - 24 pages - $99
Jan 2008 - 148 pages - $1,740
Jun 2010 - 29 pages - $125
Nov 2011 - 6 pages - $75
Jun 2011 - 44 pages - $125
Nov 2011 - 6 pages - $75
Mar 2007 - 33 pages - $2,900
May 2011 - 44 pages - $125
Dec 2010 - 30 pages - $500
Dec 2010 - 41 pages - $500
Your selection
Browse By
- Therapeutic target
- Appendicitis
- Cholangitis, sclerosing
- Colitis
- Colitis, ulcerative
- Constipation
- Crohn's disease
- Diarrhea
- Dyspepsia
- Electrolyte replacement
- Emesis
- Emesis, motion
- Esophagitis
- Flatulence
- Food poisoning
- Gastritis
- Gastroesophageal reflux disorder
- Gastrointestinal (other)
- Gastrointestinal secretions
- Gastroprokinetic
- Helicobacter pylori
- Inflammatory bowel disease
- Irritable bowel syndrome
- Nausea
- Pancreatitis
- Ulcer
- Ulcer, gastric
- Ulcer, gastroduodenal
- Ulcer, peptic
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us